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CASE REPORT

Chylothorax After Coronary Artery Bypass Surgery.
Report of a Case and Review of the Literature
Imran Khan*, Zahid M. Khan, Abdelbasset El Refy,
Ahmad Mahmood El Badry, Tarig Faisal Babiker
Department of Cardiothoracic Surgery, Al Mana General Hospital, Al Khobar, Saudi Arabia

Abstract
Chylothorax after coronary artery bypass grafting is a rare complication and leads to increased mortality and
morbidity. Because of the rarity of this complication, its management is debatable. We present the case of a 41 years old
male patient who had a left sided chylothorax after coronary artery bypass grafting. The patient was managed conservatively with low fat diet and drainage of the chylothorax. A thorough search of the literature published on the subject
was done and treatment strategies employed by various authors were studied. Various treatment options are conservative management with chest tube drainage, octreotide and low-fat diet or diet containing medium chain triglycerides.
Invasive options are video assisted thoracoscopy and thoracotomy with or without ligation of thoracic duct. An account
of the management strategies employed by various authors is presented in this report.
Keywords: Chylothorax, Coronary artery bypass grafting, Management

1. Introduction
hylothorax is the presence of lymphatic ﬂuid,
or chyle, in the thoracic cavity. The incidence
of chylothorax is 0.4e4% in esophageal procedures
to 2.5%e4.7% in congenital cardiac procedures
[1,2]. But chylothorax after coronary artery bypass
grafting has been described very rarely. This is
probably because lymphatics are valved and normally these valves are competent. Also the anatomy of the thoracic duct keeps it safe in surgical
revascularization. In most cases the thoracic duct
traverses up the chest on the right side of the aorta
and at the level of T4-T5 travels to the left side
ascending in the chest and then projects for a short
while into the neck. It ends by entering the junction of subclavian vein and internal jugular vein by
curving down. But this ‘normal’ course is found in

C

only 50e60% of the population and in 12e15%
cases, there is anomalous course and aberrant
tributaries of the duct [3]. The left anterior mediastinal lymph node chain crosses the left internal
mammary artery (LIMA) anteriorly near its origin.
It joins the thoracic duct or in some cases, enters
the venous conﬂuence directly. This chain is
vulnerable to injury during harvesting of LIMA,
especially if the mammary vein is divided proximally [4]. Injury to anomalous peri-thymic lymphatics and use of electrocautery in lymphatic rich
area rather than suturing for hemostasis are some
of the mechanisms [5]. Because of the rarity of
chylothorax after CABG, there is no consensus on
the management strategy. This report describes
the case of chylothorax after CABG and sheds light
on the previously reported cases and management
strategies.
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2. Case report
A 41 years old gentleman, known diabetic and
hypertensive, presented with chest pain, palpitations and diaphoresis. He was diagnosed to have
non-ST elevation myocardial infarction and a subsequent coronary angiography showed multivessel
coronary artery disease. The patient was scheduled
for elective coronary artery bypass grafting. The
CABG included a pedicled LIMA to left anterior
descending (LAD) artery, great saphenous vein to
right coronary artery (RCA), obtuse marginal (OM)
and diagonal coronary arteries. Left pleura was
widely opened during harvesting of the LIMA and
thymus was dissected with electrocautery. The patient had an uneventful postoperative course and
discharged on the 10th day.
Just 3 days after discharge, the patient presented
with shortness of breath and tiredness. On examination, breath sounds were greatly diminished on
left side of the chest. A postero-anterior chest X-Ray
was done that showed large left sided pleural effusion Fig. 1.
Chest drain was inserted that drained 2400 ml
milk colored ﬂuid.
The patient rapidly improved symptomatically
with drainage of the effusion. A Gram staining and
Ziel Nelson staining of the pleural ﬂuid did not show
any organism. But the initial biochemical analysis
showed triglyceride of 1575 mg/dl (normal <110 mg/
dl) and cholesterol less than 50 mg/dl. Chylothorax
was diagnosed and the patient was rendered nil by
mouth and total parenteral nutrition was started. The
chest tube drainage dropped to 1000 ml on the second day, 600 ml on the third and 300 ml on fourth
day. A low-fat diet was then started. The drainage

Fig. 1. Chest X-Ray showing left sided pleural effusion.
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decreased further and the tube was removed on day
seventh. The patient was then discharged with clear
both lung ﬁelds and in a normal and stable condition.
One month later, the patient was asymptomatic and
chest X-Ray showed no pleural effusion (Fig. 2).

3. Discussion
Chylothorax after coronary artery bypass grafting
poses a unique problem. If it doesn't respond to
conservative management, invasive management
must be adopted. This complication can lead to
deleterious consequences like immunosuppression,
dehydration, malnutrition and respiratory dysfunction in a patient who is already recovering form a
major open-heart surgery [6]. But luckily, the incidence is rare [1]. A thorough search of the available
English language literature identiﬁed less than 50
cases. Various strategies have been used to manage
this complication including a conservative approach
with chest tube drainage and dietary changes,
pharmacologic management with the use of somatostatin and its analogues and invasive management that involves thoracotomy or thoracoscopy to
control the chyle leakage.
3.1. Conservative management
Conservative management involves nil per os
(NPO), total parenteral nutrition, chest tube
drainage of the chyle, and later when the drainage
has decreased signiﬁcantly, starting a low-fat diet or

Fig. 2. Chest X-Ray on follow up.
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effects such as hypoglycemia and hypotension
should be looked for when treating patients with
octreotide. The exact mechanism of action is not
known but receptors having high afﬁnity for somatostatin have been described on human lymphatics [25]. Table 2 presents a summary of the
published cases where octreotide was used.

a diet rich in medium chain triglycerides (MCTG).
Most of the authors seem to have employed this
regimen (Table 1). Excluding long chain triglycerides from the diet ensures a decreased
chylomicron transportation to the intestinal
lymphatic ducts. It has been suggested that a 10e14
days trial of conservative management is plausible.
In case the drainage persists beyond this, invasive
strategy should be followed [7]. Some of the disadvantages of conservative management are deterioration in nutritional status and vulnerability to
infections because of depletion of lymphocytes.

3.3. Invasive management
Invasive options are VATS, thoracotomy, median
sternotomy. Most authors agree suggest that surgery should not be delayed for more than 1e2
weeks or the output remains more than 1000 ml/day
[7,27]. Historically, lymphangiography and high fat
content food has been administered before the
invasive procedure to localize the leaking site. But
high fat content food has been shown to be preferable because the ducts damaged mostly in CABG
are small in size [33]. Various strategies during
invasive management are duct ligation, pleural ﬂap
cover, biological sealants and suturing of the leaking
area [7]. If a delayed diagnosis is made, lavage and
pleurodesis should be done through VATS because

3.2. Octreotide
Octreotide is a synthetic analogue of somatostatin
which inhibits growth hormones, glucagon and insulin, more potently than somatostatin. It ha s been
used with success in GI ﬁstulae. The use of
Octreotide for post CABG chylothorax seems to
have increased recently [24]. Most authors have
used a dose of 50e100 mg subcutaneously for 10e14
days. If somatostatin is used, it must be used intravenously because of its short half-life [6]. Side

Table 1. Summary of the reported cases of conservative management of chylothorax after coronary artery bypass grafting.
Author

Procedure

Age/
Gender

LIMA/
RIMA

Site

Surgery to
diagnosis
duration
(days)

Management

Weber et al., 1981 [8]

CABG

55 y/M

LIMA

L&M

2

Zakhour et al., 1981 [9]
Zakhour et al., 1981 [9]
Kshetry et al., 1982 [10]
Teba et al., 1985 [11]

73
59
51
51

y/M
y/M
y/M
y/F

LIMA
N
N
N

L
L&M
L
L

90
2
60
7

Davies et al., 1994 [12]
Smith et al., 1994 [13]
Smith et al., 1994 [13]
Zaidenstein et al., 1996 [5]
Mohanty et al., 1998 [14]

CABG
CABG
CABG
CABG
þ MVR
CABG
CABG
CABG
CABG
CABG

Chet tube drainage, MCTG, drain removed on 12th POD,
discharged home on 14th POD
Chest tube drainage, MCTG, drainage resolved on 21st day
Chest tube drainage, MCTG, resolved after 5 days
Chest tube drainage, resolved after 4 days
Chest tube drainage, resolved after 17 days

48
60
47
70
56

y/M
y/M
y/M
y/F
y/M

LIMA
LIMA
LIMA
LIMA
LIMA

L
L
L
L
L

21
14
7
42
8

Sharpe et al., 1999 [15]

CABG

63 y/F

N

L&M

11

Priebe et al., 1999 [16]

CABG

75 y/F

LIMA

L&M

30

Brancaccio et al., 2001 [17]
Fahimi et al., 2001 [18]
Abid et al., 2003 [19]

CABG
CABG
CABG

64 y/M
51 y/M
58 y/M

LIMA
LIMA
LIMA

L
L
L

6
UK
3

Halldorsson et al., 2006 [20]
karimi et al., 2010 [21]
Mandak et al., 2011 [22]
Sabzi et al., 2017 [23]

CABG
CABG
CABG
CABG

47
53
76
43

N
LIMA
LIMA
LIMA

R
L
L
L

10
2
9
0

y/F
y/M
y/F
y/M

Chest tube drainage, MCTG, resolved after 4 weeks
Chest tube drainage, MCTG, resolved after 15 days
Chest tube drainage, MCTG, resolved after 14 days
Chest tube drainage, low fat diet, resolved after 16 days
Chest tube drainage, MCTG, resolved after 22 days, the
sternum was rewired at day 9
Chest tube drainage, TPN, Pigtail drainage initially and then
pericardial window later-on for chylopericardium
initially, resolved after 14 days
Chest tube drainage, discharged after 3 days as
the chest X-Ray was clear,
readmitted 2 weeks later with relapse of
chylothorax, low fat diet,
pleurodesis through chest tube, resolved after 2 months
Chest tube drainage, resolved after 11 days
Chest tube drainage, MCTG
Chest tube drainage, MCTG, Talc pleurodesis after 8 days,
resolved after one week
Chest tube drainage, resolved after 10 days
Chest tube drainage, low fat diet, resolved after 27 days
Chest tube drainage, NPO, TPN, resolved after 16 days
Chest tube drainage, low fat diet, resolved after 10 days

Table 2. A summary of the published cases of chylothorax after coronary artery bypass grafting where octreotide was used in the management.
Author

Procedure

Age/
Gender

LIMA/
RIMA

Site

Surgery to
diagnosis
duration
(days)

Management and Use of Octreotide/Somatostatin

Perez et al., 1999 [26]

68 y/M

UK

L&M

10

Kelly et al., 2000 [27]

CABG
þ AVR
CABG

77 y/M

L

L

18

Gabbieri et al., 2004 [28]

CABG

67 y/F

LIMA

L

10

Kilic et al., 2005 [29]

CABG

66 y/F

LIMA

L

12

Barbetakis
et al., 2006 [30]
Altun et al., 2015 [6]

CABG

78 y/M

LIMA

L

27

Chest tube drainage, TPN, MCTG, Octreotide, resolved
after 10 days
Chest tube drainage, NPO, TPN, Octreotide (50 mg SC
TID for 14 days), resolved after 14 days
Chest tube drainage, TPN, NPO, Octreotide (100 mg SC
TID), resolved after 28 days
Chest tube drainage, MCTG, Octreotide (100 mg SC
TID), resolved after 10 days
Chest tube drainage, MCTG, Octreotide

CABG

60 y/M

LIMA

UK

2

Altun et al., 2015 [6]

CABG

46 y/M

LIMA

UK

3

Owais et al., 2015 [31]

CABG

76 y/F

LIMA

L

15

Waikar et al., 2018 [24]

CABG

52 y/M

LIMA

L

6

Mukherjee
et al., 2016 [32]

CABG

56 y/M

LIMA

L

3

Mukherjee
et al., 2016 [32]

CABG

50 y/M

LIMA

L

14

Chest tube drainage, NPO, TPN, Somatostatin infusion
@ 3.5 mg/kg/Hr, increased to 7 mg/Kg/Hr, resolved after
13 days
Chest tube drainage, NPO, TPN, Somatostatin infusion,
resolved after 7 days
Chest tube drainage, MCTG, Octreotide (100 mg SC 8
hourly), resolved after 7 days
Chest tube drainage, NPO, TPN, later on MCTG,
Octreotide (100 mg SC 8 hourly), pleurodesis done with
7.5% povidone iodine on POD 11th, resolved after 14
days
Chest tube drainage, Octreotide, Tal pleurodesis after 30
days of conservative management, lung expanded after
two days of pleurodesis
Chest tube drainage, Octreotide, Tal pleurodesis after 29
days of conservative management

Table 3. A summary of the reported cases of invasive management of chylothorax after coronary artery bypass grafting.
Author

Procedure

Age/
Gender

LIMA/
RIMA

Site

Surgery to
diagnosis
duration
(days)

Management

Dilello et al., 1987 [36]

CABG

53 y/M

LIMA

L

9

Czarnecki et al., 1988
[37]
Chaiyaroji et al., 1991
[38]
Inderbitzi et al., 1992
[39]
Bogers et al., 1993 [7]

CABG

61 y/F

R

42

CABG

69 y/F

LIMA
and RIMA
LIMA

L

6

RedoCABG
CABG

69 y/M

UK

L

2

Chest tube on POD 13th, supraclavicular approach to
thoracic duct, multiple entries of TD to the vein were
noticed, leakage ligated, drainage did not decrease so a
left thoracotomy was done on POD 31, a diffuse leak
from adhesion in the junctional area of mammary
pedicle, subclavian vein and artery was noted, pleural
flap was raised and the area sprayed with biological
glue, the flap closed over the area, chyle drainage
resolved after POD 7
Conservative management failed after 10 days, right
thoracotomy and ligation of the duct at diaphragm
Conservative management failed after 18 days, left
thoracotomy and clipping at the leakage site
Left VATS, fibrin glue spray

41 y/M

LIMA

L

1

Wood et al., 1994 [40]

CABG

69 y/M

LIMA

L

3

Janssen et al., 1994 [41]

CABG

58 y/M

LIMAL

L

35

Yamaguchi et al., 1996
[42]

CABG

64 y/M

LIMA

L

2

Conservative management fialed after 35 days, left
thoracotomy and ligation at injury site
Conservative failed after 7 days, left VATS ligation at
injury site (proximal LIMA)
Conservative failed after 2 weeks, left VATS and
clipping of thoracic duct behind the aortic arch
Conservative management failed after 3 weeks, left
thoracotomy
(continued on next page)
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Table 3. (continued )
Author

Procedure

Age/
Gender

LIMA/
RIMA

Site

Surgery to
diagnosis
duration
(days)

Management

Felz et al., 1997 [43]
Pego-Fernandez et al.,
1997 [34]
Venturini et al., 1999
[44]
Fahimi et al., 2001 [18]
Riquet et al., 2004 [45]

CABG
CABG

50 y/F
38 y/M

LIMA
LIMA

L
L

56
90

Left VATS ligation at injury site
VATS for cleaning and lavage of thorax only

CABG

67 y/M

LIMA

L

70

Left thoracotomy, ligation of the duct

CABG
CABG

49 y/M
59 y/F

LIMA
LIMA

L
L

UK
UK

68 y/F

LIMA

L

3

Choong et al., 2006 [4]

CABG þ
ASD repair
CABG

Left VATS, fibrin glue
Left thoracotomy, ligation at injury site (left anterior
mediastinal lymph node chain)
Left VATS, Talc pleurodesis

63 y/M

LIMA

L

2

Paul et al., 2009 [35]

CABG

65 y/M

UK

UK

UK

Deguchi et al., 2015 [47]

CABG

78 y/F

LIMA
and RIMA

R

3

Waliany et al., 2018 [48]

CABG

62 y/M

LIMA

L

13

Falode et al., 2005 [46]

adhesions in the area of thoracic duct following
surgery will make dissection in this area very difﬁcult and dangerous [34]. Most authors have
preferred a left thoracotomy or VATS and clipping
or ligation of the leakage area but a right thoracotomy and mass ligation of the duct at the diaphragm
has also been done [35]. Table 3.

4. Conclusion
Chylothorax is a rare complication after coronary
artery bypass grafting. Patients with a pedicled harvesting of left internal mammary artery harvesting
are more prone to this complication. It appears from
the published reports that most of the patients can be
managed with a conservative management. In case
of failure of conservative management, early invasive
strategy should be resorted to avoid complications.
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Conservative management failed after 35 days, right
thoracotomy and ligation at injury site (severed duct
identified in thymic area)
Conservative failed after 14 days, right thoracotomy and
duct ligation at diaphragm
Conservative failed after 10 days, median sternotomy
and ligation at injury site (injured lymphatic on right
side of innominate vein)
Chest tube drainage, MCTG followed by TPN,
thoracoscopic Talc pleurodesis on POD 33 but drainage
remained high, so Doxycycline pleurodesis through
chest tube on POD 40, course complicated by Yellow
Nail Syndrome, resolved ultimately
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